@RenuEapen, a leader in urology & robotic surgery and host of @gu-cast.bsky.social, shares her insights on mentorship & diversity in today's Herald Sun.
More: www.petermac.org/about-us/new...
@RenuEapen, a leader in urology & robotic surgery and host of @gu-cast.bsky.social, shares her insights on mentorship & diversity in today's Herald Sun.
More: www.petermac.org/about-us/new...
Tomorrow we stand and get back to the fight against the terrible disease that took one of our best, brightest, and kindest.
Love you forever, Felix.
Tomorrow we stand and get back to the fight against the terrible disease that took one of our best, brightest, and kindest.
Love you forever, Felix.
I am sincerely grateful to everyone who has supported me on this journey. Together, we can continue to make a meaningful difference!
@jameabraham.bsky.social @drchoueiri.bsky.social @oncoalert.bsky.social
ascopost.com/news/novembe...
I am sincerely grateful to everyone who has supported me on this journey. Together, we can continue to make a meaningful difference!
@jameabraham.bsky.social @drchoueiri.bsky.social @oncoalert.bsky.social
ascopost.com/news/novembe...
dx.doi.org/10.1056/NEJM...
RP vs. WW for clinically detected #prostatecancer reduces CSM 48% and *ACM* by 26%. NNT down to 6. Clear benefit to treatment of clinically detectable disease if (and only if) your pt has a very long life expectancy. #pcsm
dx.doi.org/10.1056/NEJM...
RP vs. WW for clinically detected #prostatecancer reduces CSM 48% and *ACM* by 26%. NNT down to 6. Clear benefit to treatment of clinically detectable disease if (and only if) your pt has a very long life expectancy. #pcsm
Read the full review here: https://buff.ly/3ZeWEOr
#UroSky #UroSoMe